Business Description
Sera Prognostics Inc
NAICS : 621512
SIC : 8734
2749 East Parleys Way, Suite 200, Salt Lake City, UT, USA, 84109
Description
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 66.7 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 3.57 | |||||
| Beneish M-Score | 2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.62 | |||||
| 9-Day RSI | 65.6 | |||||
| 14-Day RSI | 64.68 | |||||
| 6-1 Month Momentum % | -74 | |||||
| 12-1 Month Momentum % | -84.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.8 | |||||
| Quick Ratio | 14.8 | |||||
| Cash Ratio | 14.64 | |||||
| Days Sales Outstanding | 83.18 | |||||
| Days Payable | 3811.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.39 | |||||
| Operating Margin % | -27900 | |||||
| Net Margin % | -27921.82 | |||||
| ROE % | -58.04 | |||||
| ROA % | -35.13 | |||||
| ROIC % | -169.95 | |||||
| ROC (Joel Greenblatt) % | -2434.5 | |||||
| ROCE % | -36.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 433.33 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.69 | |||||
| EV-to-EBIT | 0.54 | |||||
| EV-to-EBITDA | 0.55 | |||||
| EV-to-Revenue | -149.72 | |||||
| EV-to-Forward-Revenue | 6.31 | |||||
| EV-to-FCF | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 0.81 | |||||
| Price-to-Net-Cash | 0.82 | |||||
| Earnings Yield (Greenblatt) % | 185.19 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:SERA
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.165 | ||
| EPS (TTM) ($) | -1.57 | ||
| Beta | 0 | ||
| Volatility % | 85.76 | ||
| 14-Day RSI | 64.68 | ||
| 14-Day ATR ($) | 0.217366 | ||
| 20-Day SMA ($) | 2.27 | ||
| 12-1 Month Momentum % | -84.44 | ||
| 52-Week Range ($) | 1.15 - 11.9 | ||
| Shares Outstanding (Mil) | 31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sera Prognostics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||